Quotes by Pat Donnelly

“Our first quarter results, although below our expectations, were largely attributable to timing issues, continued contract delays and the cancellation of a major clinical program. Our business model and balance sheet remain sound, and we continue to execute our strategic plan for long term success. During the quarter, new business awards finished at $86.7 million, following a very robust fourth quarter of $161.9 million. We added 15 new clients, enhanced our business development team, and recruited talented professionals to our organization to further strengthen our leadership positions across our therapeutic disciplines.”

“By extending our geographic footprint into India we are greatly increasing our access to clinical sites and patients, as well as establishing a highly efficient data management platform to accommodate the global requirements of our clients.”